|
|
||||||||
1-Deficient Mice Requires CD4+ T Cells1




,
Departments of
*
Pathology and
Microbiology and Immunology, and
The Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, NH 03756
The etiology of autoimmune liver disease is poorly understood. BALB/c mice deficient in the immunoregulatory cytokine TGF-
1 spontaneously develop necroinflammatory liver disease, but the immune basis for the development of this pathology has not been demonstrated. Here, we show that BALB/c-TGF-
1-/- mice exhibit abnormal expansion in hepatic mononuclear cells (MNCs) compared with wild-type littermate control mice, particularly in the T cell and macrophage lineages. To test whether lymphocytes of the adaptive immune system are required for the spontaneous development of necroinflammatory liver disease, BALB/c-TGF-
1-/- mice were rendered deficient in B and T cells by crossing them with BALB/c-recombinase-activating gene 1-/- mice. BALB/c-TGF-
1-/-/recombinase-activating gene 1-/- double-knockout mice showed extended survival and did not develop necroinflammatory liver disease. The cytolytic activity of BALB/c-TGF-
1-/- hepatic lymphocytes was assessed using an in vitro CTL assay. CTL activity was much higher in BALB/c-TGF-
1-/- hepatic MNCs compared with littermate control hepatic MNCs and was particularly pronounced in the CD4+ T cell subset. Experimental depletion of CD4+ T cells in young BALB/c-TGF-
1-/- mice prevented the subsequent development of necroinflammatory liver disease, indicating that CD4+ T cells are essential for disease pathogenesis in vivo. These data definitively establish an immune-mediated etiology for necroinflammatory liver disease in BALB/c-TGF-
1-/- mice and demonstrate the importance of CD4+ T cells in disease pathogenesis in vivo. Furthermore, TGF-
1 has a critical role in homeostatic regulation of the hepatic immune system, inhibiting the development or expansion of hepatic cytolytic CD4+ T cells.
Related articles in The JI:
This article has been cited by other articles:
![]() |
R. T. Robinson, J. Wang, J. G. Cripps, M. W. Milks, K. A. English, T. A. Pearson, and J. D. Gorham End-Organ Damage in a Mouse Model of Fulminant Liver Inflammation Requires CD4+ T Cell Production of IFN-{gamma} but Is Independent of Fas J. Immunol., March 1, 2009; 182(5): 3278 - 3284. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ghannad, D. Nica, M. I. Garcia Fulle, D. Grenier, E. E. Putnins, S. Johnston, A. Eslami, L. Koivisto, G. Jiang, M. D. McKee, et al. Absence of {alpha}v{beta}6 Integrin Is Linked to Initiation and Progression of Periodontal Disease Am. J. Pathol., May 1, 2008; 172(5): 1271 - 1286. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Wrzesinski, Y. Y. Wan, and R. A. Flavell Transforming Growth Factor-{beta} and the Immune Response: Implications for Anticancer Therapy Clin. Cancer Res., September 15, 2007; 13(18): 5262 - 5270. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Robinson and J. D. Gorham TGF-beta1 Regulates Antigen-Specific CD4+ T Cell Responses in the Periphery J. Immunol., July 1, 2007; 179(1): 71 - 79. [Abstract] [Full Text] [PDF] |
||||
![]() |
I.-K. Park, L. D. Shultz, J. J. Letterio, and J. D. Gorham TGF-{beta}1 Inhibits T-bet Induction by IFN-{gamma} in Murine CD4+ T Cells through the Protein Tyrosine Phosphatase Src Homology Region 2 Domain-Containing Phosphatase-1 J. Immunol., November 1, 2005; 175(9): 5666 - 5674. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Lin, S. L. Martin, L. Xia, and J. D. Gorham TGF-{beta}1 Uses Distinct Mechanisms to Inhibit IFN-{gamma} Expression in CD4+ T Cells at Priming and at Recall: Differential Involvement of Stat4 and T-bet J. Immunol., May 15, 2005; 174(10): 5950 - 5958. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Devitt, K. G. Parker, C. A. Ogden, C. Oldreive, M. F. Clay, L. A. Melville, C. O. Bellamy, A. Lacy-Hulbert, S. C. Gangloff, S. M. Goyert, et al. Persistence of apoptotic cells without autoimmune disease or inflammation in CD14-/- mice J. Cell Biol., December 20, 2004; 167(6): 1161 - 1170. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |